临沧阴道少量褐色分泌物临沧那间做处女膜修复好,临沧早孕试纸一深一浅很淡,临沧做宫颈息肉手术疼吗,临沧小便后有血就几滴,临沧阴虱治疗的最好方法,临沧阴道内很多白色分泌物,临沧阴道长小肉芽怎么治疗

SAN DIEGO (KGTV) — A small San Diego biotech is trying to give face masks an added layer of defense by spraying the liner with a biological bait designed to be a mousetrap for the coronavirus.AXIM Biotechnologies is also developing a next-generation rapid antibody test that the company says is the first of its kind to detect “neutralizing antibodies.” The neutralizing antibody test should be available for sale in the next few weeks, said CEO John Huemoeller.Both the test and the surgical mask are based on the same technology: a synthetic protein AXIM created that mimics ACE2.ACE2 is a receptor protein found in your body on the surface of cells. The coronavirus likes to bind to it to infiltrate cells, so the company decided to coat the inner lining of a surgical mask with the protein as an added barrier.“They lock to each other just like they do in your body. They lock on the mask. So when we spray the mask with that virus-binding protein, it's there permanently. It can be washed. It's not coming off,” Huemoeller said.“That's the whole idea is to get [the virus] to bind to something, so it cannot go into your respiratory system,” he added.AXIM’s mask is still a ways off from hitting the market. Huemoeller said it needs to undergo further testing to get FDA approval and the company is still looking for a manufacturing partner. The company is hoping to release the enhanced mask by the middle of next year.“We’re hoping that maybe [the FDA will] steamline it because this is something that can save lives,” Huemoeller said.With fewer than 10 scientists, AXIM is a small biotech based in Sorrento Valley. But the company thinks it's poised to be at the center of the second wave of antibody tests for so-called neutralizing antibodies.“When the FDA got our application they didn't know what neutralizing antibodies were. And now everybody's talking about neutralizing antibodies,” said Huemoeller.Not all antibodies function the same. Some antibodies bind to the virus but still allow the pathogen to infiltrate cells. Other antibodies, called neutralizing antibodies, bind to the virus and actually prevent further infection.AXIM’s lateral flow assay antibody test, dubbed Tru-19, takes a drop of blood and can return results in 10 minutes to determine if someone has neutralizing antibodies, according to Huemoeller.In addition to uses at doctors’ offices, the company said the test would have immediate applications at labs processing convalescent plasma.Since as many as one-third of people who recover from COVID-19 do not produce neutralizing antibodies, Huemoeller said the test could help determine which patients would be optimal candidates to donate plasma. 2693

SAN DIEGO (KGTV) - A tow truck driver helped San Diego Police capture a man who the driver said was starting a fire Thursday along Interstate 15 in central San Diego.Police said the tow truck driver reported the man near the 15 and 94 freeways in Mount Hope about 1 p.m.Officers handcuffed the man and placed him inside a patrol car, but he managed to get out of his restraints. Police said he fought back and they removed him from the car to restrain him again.“The gentleman attempted to bite two of the officers on their hands as they were attempting to place him in the body wrap system,” said SDPD Sgt. Nathan Chambers.Arson investigators who responded to the fire scene found charred wood and grass. There was no evidence of a large fire.10News asked police if the man is connected to other recent fires in the area but officers said that has not been determined. The man was not charged with arson Thursday. 932

SAN DIEGO (KGTV) - A woman involved in a Lamborghini crash this week has died, the San Diego Medical Examiner (ME) confirmed Wednesday.Stephanie Rivera, 26, was ejected from the crash on North Harbor Drive and Broadway just after 2 a.m. Sunday, Nov. 5 after the driver, identified as 33-year-old Michael Llamas, lost control of the exotic vehicle at a high rate of speed, police said earlier this week.RELATED COVERAGE: 432

SAN DIEGO (KGTV) -- Activists with 'March Without Borders' are ready to welcome migrants from Central America heading to the United States with the migrant caravan.The supporters began an eight-day march from Los Angeles on April 22 and plan to meet the migrants at the San Ysidro Port of Entry on Sunday.On Saturday they marched throughout San Diego, beginning from Centro Cultural de la Raza in Balboa Park and ending in Chicano Park. Migrants are expected to ask for asylum at the San Ysidro Port of Entry sometime Sunday morning. 546

SAN DIEGO (KGTV) — A Sorrento Valley company is working to create an implant that will help people kick their addiction to both opioids and alcohol.BioCorRx, based in Orange County, is developing the implant. They chose San Diego-based Irisys Therapeutics to help them build it."It’s not going to fix the opioid crisis," says BioCorRx CEO Brady Granier. "But it’s going to be another tool in a tool chest of those people looking for another solution and one that will help them get through the cravings."The implant uses Naltrexone, a drug already approved by the FDA as an every-day pill or a once-per-month shot. Naltrexone blocks receptors in the brain so that opioids or alcohol won't have any effect on people who use them. It also helps curb cravings."As long as it’s blocking the receptor, the opioids come in, and they can’t engage with that receptor to give you the euphoria or the respiratory depression that leads to overdose," says Granier. "It’s protecting you."Granier says creating an implant that lasts three months will make it more likely that people will be able to beat their addition. The implant, named BICX102, would be implanted into a person's stomach fat and dissolve slowly over three months."The goal is to give someone a longer period of time to address those issues without the intrusive cravings coming in," he says. "A lot of behavioral changes can take place in 90 days that you can’t do in 30."Granier's company just received a .7 million grant from the National Institute on Drug Abuse. It will last two years, which Granier says will fund the research through the development of the implant and some early testing.He's hoping to start human testing by 2020.Granier says implants like the one he is hoping to create are already available in other countries. But the FDA has yet to approve one in the US, where standards are more strict."The first pellet you make needs to be exactly the same as the 10,000th," he says. "It has to be a precise process."It's personal for Granier, who has family members with addiction in their past. He also worked as a nurse before starting his company. Granier says he saw the destructive effects of addiction every day. Now he's hoping to find a solution."It’s rare to find a good opportunity where you can make a social impact and be an entrepreneur at the same time," he says. 2358